Artelo Biosciences Inc.

NASDAQ: ARTL · Real-Time Price · USD
10.06
-0.03 (-0.30%)
At close: Aug 15, 2025, 3:49 PM
10.25
1.89%
After-hours: Aug 15, 2025, 07:49 PM EDT

Artelo Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-3.15M -2.38M -3.81M -1.2M -2.51M -2.59M -3.24M -2.61M -1.78M -2.29M -3.48M -2.39M -2.47M -1.95M -2.55M -1.89M -2.25M -1.87M
Interest Income
1K 7K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1K 1K 2K 544.00 636.00 253.00
Pretax Income
-3.22M -2.37M -3.78M -1.13M -2.43M -2.48M -3.07M -2.45M -1.6M -2.17M -3.34M -2.33M -2.45M -1.97M -2.55M -1.89M -2.25M -1.87M
Net Income
-3.22M -2.37M -3.78M -1.13M -2.43M -2.48M -3.07M -2.45M -1.6M -2.17M -3.34M -2.33M -2.45M -1.97M -2.55M -1.89M -2.25M -1.87M
Selling & General & Admin
1.28M 995K 1.34M 870K 827K 1.08M 1.12M 1.03M 1.03M 1.06M 1.75M 1.32M 1.42M 1.48M 1.28M 1.27M 1.3M 1.2M
Research & Development
1.87M 1.38M 2.48M 325K 1.69M 1.51M 2.12M 1.58M 752K 1.24M 1.73M 1.08M 1.06M 464K 1.27M 615.46K 951.2K 663.36K
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
3.15M 2.38M 3.81M 1.2M 2.51M 2.59M 3.24M 2.45M 1.78M 2.29M 3.48M 2.39M 2.47M 1.95M 2.55M 1.89M 2.25M 1.87M
Interest Expense
72K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 5K n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
3.15M 2.38M 3.81M 1.2M 2.51M 2.59M 3.24M 2.45M 1.78M 2.29M 3.48M 2.39M 2.47M 1.95M 2.55M 1.89M 2.25M 1.87M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a 165K n/a -124K -140K -69K -22K 19K -4K -225 -1.62K -1.59K
Shares Outstanding (Basic)
574K 3.28M 539.86K 3.23M 3.23M 3.2M 531.49K 491.5K 476K 476K 471.5K 474.83K 471.67K 470K 338.23K 338.23K 256.79K 188.67K
Shares Outstanding (Diluted)
574K 3.28M 539.86K 3.23M 3.23M 3.2M 531.49K 491.5K 476K 476K 472.17K 474.83K 471.73K 470.01K 338.23K 338.23K 256.79K 188.74K
EPS (Basic)
-5.61 -0.72 -7 -0.35 -0.75 -0.78 -5.78 -0.83 -0.56 -0.72 -1.13 -0.79 -0.86 -0.7 -1.26 -0.06 -1.46 -1.65
EPS (Diluted)
-5.61 -0.72 -7 -0.35 -0.75 -0.78 -5.78 -0.83 -0.56 -0.72 -1.13 -0.79 -0.86 -0.7 -1.26 -0.06 -1.46 -1.65
EBITDA
-3.15M -2.38M -3.81M -1.2M -2.51M -2.59M -3.07M 165K -1.97M -2.42M -3.48M -2.39M -2.49M -1.93M -2.56M -1.89M -2.25M -1.87M
EBIT
-3.15M -2.38M -3.81M -1.2M -2.51M -2.59M -3.07M n/a -1.78M -2.29M n/a n/a -2.47M -1.95M -2.55M -1.89M -2.25M -1.87M
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a 2.61M -185K -124K -72K 27.08K -21K 20K 4K 225.00 61.00 62.00